Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine

European Journal of Clinical Pharmacology

Volumn 57, Issue 4, 2001, Pages 275-284

  Breithaupt Grogler K ^a   Ungethum W ^b   Meurer Witt, B ^c   Belz, G G ^a  

^a ZeKaPha GmbH   (Germany)

^b MERCK KGAA   (Germany)

^c Hormosan Kwizda GmbH   (Germany)

Author keywords

Imidapril; Pharmacokinetic dynamic interaction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; IMIDAPRIL; IMIDAPRILAT; NILVADIPINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG SAFETY; HEART FAILURE; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; BISOPROLOL; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; DIURETICS; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; HEMODYNAMIC PROCESSES; HUMANS; HYDROCHLOROTHIAZIDE; IMIDAZOLES; IMIDAZOLIDINES; MALE; NIFEDIPINE; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0034896431     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280100323     Document Type: Article

References (46)

1. Combination antihypertensive therapy: Does it have a role in rational therapy?
2. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension
3. Blood pressure and aortic elastic properties - Verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy
4. The importance of drug combinations for effective control of hypertension
5. Use of angiotensin-converting enzyme inhibitors as monotherapy and in combination with diuretics and calcium channel blockers
6. The use of angiotensin converting enzyme inhibitors in combination with other antihypertensive agents
7. Cilazapril with adjunctive hydrochlorothiazide. Analysis of safety and efficacy in hypertensive patients not responding to cilazapril alone
8. Antihypertensive effects of combined lisinopril and hydrochlorothiazide in elderly patients with systodiastolic or systolic hypertension: Results of a multi-center trial
9. Fosinoprilhydrochlorothiazide: Single close and steady-state pharmacokinetics and pharmacodynamics
10. Influence of the angiotensin converting enzyme inhibitor cilazapril, the β-blocker propranolol and their combination on haemodynamics in hypertension
11. Lisinopril combined with atenolol in the treatment of hypertension
12. Enalapril versus combined enalapril and nadolol treatment: Effects on blood pressure, heart rate, humoral variables, and plasma potassium at rest and during exercise in hypertensive patients
13. Vascular protective effects of ACE inhibitors and calcium antagonists: Theoretical basis for a combination therapy in hypertension and other cardiovascular diseases
14. Vascular remodeling and endothelial function in hypertensive patients: Effects of antihypertensive therapy
15. Combinations in the treatment of hypertension: ACE inhibitors and calcium antagonists
16. Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina
17. Nilvadipine: Profile of a new calcium antagonist. An overview
18. Studies on angiotensin I converting enzyme (ACE) inhibitory effect of imidapril. Inhibition of various tissue ACEs in vitro
19. Imidapril hydrochloride in essential hypertension: A double-blind comparative study using enalapril maleate as a control
20. Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failure
21. Dose-response relationships and plasma concentrations of digitalis glycosides in man
22. Comparison of four noninvasive techniques to measure stroke volume: Dual-beam Doppler echoaortography, electrical impedance cardiography, mechanosphygmography and M-mode echocardiography of the left ventricle
23. KINPAK - A new program package for standardized evaluation of kinetic parameters
24. Studies with two investigational interventions: A simple model to assess their effects and interaction
25. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin healthy volunteers
26. Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with impaired liver function
27. Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with chronic renal failure
28. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients
29. Pharmacokinetic drug interactions with ACE inhibitors
30. Spirapril: Pharmacokinetic properties and drug interactions
31. Effect of hydrochlorothiazide on the pharmacokinetics of enalapril in hypertensive patients with varying renal function
32. Fosinopril and hydrochlorothiazide combination versus individual components: Lack of a pharmacokinetic interaction
33. The clinical pharmacokinetics of quinapril
34. Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and β-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients
35. Drug interactions with calcium antagonists
36. Effectiveness and metabolic effects of perindopril and diuretics combination in primary hypertension
37. Beta adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics
38. Intrinsic and reflex actions of verapamil and nifedipine: Assessments in normal subjects by non-invasive techniques and autonomic blockade
39. Cardiac effects of calcium antagonists in systemic hypertension
40. Effect of the calcium antagonist nilvadipine on haemodynamics at rest and during cold stimulation in essential hypertension
41. Differential effects of two dihydropyridine calcium antagonists in humans
42. The potential role of calcium antagonists in the management of congestive heart failure: Initial experience with lacidipine
43. Calcium antagonists in antihypertensive combination therapy
44. Antihypertensive effects of moexipril, a new ACE inhibitor, as add-on therapy to nifedipine in patients with essential hypertension
45. Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone
46. Combined enalapril and felodipine extended release (ER) for systemic hypertension